Cullen/Frost Bankers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.05M | Buy |
209,637
+6,282
| +3% | +$164K | 0.05% | 223 |
|
|
2026
Q1 | $5.71M | Sell |
203,355
-8,281
| -4% | -$220K | 0.06% | 204 |
|
|
2025
Q4 | $5.27M | Sell |
211,636
-2,912
| -1% | -$73.4K | 0.06% | 213 |
|
|
2025
Q3 | $5.47M | Sell |
214,548
-18,952
| -8% | -$468K | 0.06% | 206 |
|
|
2025
Q2 | $5.66M | Sell |
233,500
-49,949
| -18% | -$1.16M | 0.07% | 194 |
|
|
2025
Q1 | $7.18M | Sell |
283,449
-103,406
| -27% | -$2.71M | 0.1% | 175 |
|
|
2024
Q4 | $10.3M | Sell |
386,855
-32,655
| -8% | -$886K | 0.14% | 147 |
|
|
2024
Q3 | $12.1M | Sell |
419,510
-17,313
| -4% | -$505K | 0.17% | 130 |
|
|
2024
Q2 | $12.2M | Sell |
436,823
-140,266
| -24% | -$3.86M | 0.18% | 126 |
|
|
2024
Q1 | $16M | Buy |
577,089
+34,037
| +6% | +$944K | 0.24% | 104 |
|
|
2023
Q4 | $15.6M | Sell |
543,052
-58,539
| -10% | -$1.77M | 0.25% | 100 |
|
|
2023
Q3 | $20M | Sell |
601,591
-1,440
| -0.2% | -$50.9K | 0.35% | 77 |
|
|
2023
Q2 | $22.1M | Sell |
603,031
-5,179
| -0.9% | -$202K | 0.38% | 70 |
|
|
2023
Q1 | $24.8M | Buy |
608,210
+11,712
| +2% | +$506K | 0.45% | 62 |
|
|
2022
Q4 | $30.6M | Buy |
596,498
+67,316
| +13% | +$3.23M | 0.58% | 46 |
|
|
2022
Q3 | $23.2M | Buy |
529,182
+16,390
| +3% | +$796K | 0.53% | 48 |
|
|
2022
Q2 | $26.9M | Buy |
512,792
+8,017
| +2% | +$409K | 0.6% | 41 |
|
|
2022
Q1 | $26.1M | Buy |
504,775
+10,645
| +2% | +$552K | 0.51% | 52 |
|
|
2021
Q4 | $29.2M | Sell |
494,130
-8,944
| -2% | -$443K | 0.55% | 47 |
|
|
2021
Q3 | $21.6M | Buy |
503,074
+10,986
| +2% | +$487K | 0.44% | 61 |
|
|
2021
Q2 | $19.3M | Buy |
492,088
+132,363
| +37% | +$5.15M | 0.39% | 71 |
|
|
2021
Q1 | $13M | Buy |
359,725
+638
| +0.2% | +$22.7K | 0.29% | 92 |
|
|
2020
Q4 | $13.2M | Sell |
359,087
-23,315
| -6% | -$855K | 0.3% | 86 |
|
|
2020
Q3 | $13.3M | Buy |
382,402
+584
| +0.2% | +$20.5K | 0.33% | 82 |
|
|
2020
Q2 | $11.8M | Buy |
381,818
+32,307
| +9% | +$1.1M | 0.31% | 90 |
|
|
2020
Q1 | $10.8M | Buy |
349,511
+40,452
| +13% | +$1.38M | 0.38% | 78 |
|
|
2019
Q4 | $11.5M | Buy |
309,059
+34,786
| +13% | +$1.24M | 0.31% | 97 |
|
|
2019
Q3 | $9.35M | Buy |
274,273
+10,964
| +4% | +$399K | 0.28% | 108 |
|
|
2019
Q2 | $10.8M | Buy |
263,309
+23,752
| +10% | +$943K | 0.33% | 97 |
|
|
2019
Q1 | $9.65M | Buy |
239,557
+1,327
| +0.6% | +$53.1K | 0.3% | 106 |
|
|
2018
Q4 | $9.87M | Buy |
238,230
+8,809
| +4% | +$366K | 0.37% | 89 |
|
|
2018
Q3 | $9.59M | Sell |
229,421
-14,731
| -6% | -$567K | 0.3% | 102 |
|
|
2018
Q2 | $8.4M | Sell |
244,152
-21,642
| -8% | -$740K | 0.26% | 112 |
|
|
2018
Q1 | $8.95M | Sell |
265,794
-11,191
| -4% | -$385K | 0.26% | 114 |
|
|
2017
Q4 | $9.52M | Sell |
276,985
-14,267
| -5% | -$486K | 0.3% | 109 |
|
|
2017
Q3 | $9.87M | Sell |
291,252
-11,276
| -4% | -$362K | 0.32% | 104 |
|
|
2017
Q2 | $9.64M | Sell |
302,528
-4,464
| -1% | -$141K | 0.32% | 107 |
|
|
2017
Q1 | $9.96M | Sell |
306,992
-14,112
| -4% | -$445K | 0.34% | 103 |
|
|
2016
Q4 | $9.89M | Sell |
321,104
-10,139
| -3% | -$310K | 0.34% | 98 |
|
|
2016
Q3 | $10.6M | Buy |
331,243
+2,693
| +0.8% | +$90K | 0.38% | 94 |
|
|
2016
Q2 | $11M | Sell |
328,550
-57,597
| -15% | -$1.84M | 0.41% | 88 |
|
|
2016
Q1 | $10.9M | Sell |
386,147
-874
| -0.2% | -$25K | 0.41% | 89 |
|
|
2015
Q4 | $11.9M | Buy |
387,021
+13,070
| +3% | +$411K | 0.45% | 83 |
|
|
2015
Q3 | $11.1M | Sell |
373,951
-1,060
| -0.3% | -$34K | 0.44% | 79 |
|
|
2015
Q2 | $11.9M | Sell |
375,011
-1,541
| -0.4% | -$50.2K | 0.44% | 80 |
|
|
2015
Q1 | $12.4M | Sell |
376,552
-3,346
| -0.9% | -$106K | 0.47% | 73 |
|
|
2014
Q4 | $11.2M | Buy |
379,898
+24,646
| +7% | +$707K | 0.43% | 76 |
|
|
2014
Q3 | $9.97M | Buy |
355,252
+5,937
| +2% | +$167K | 0.4% | 85 |
|
|
2014
Q2 | $9.84M | Sell |
349,315
-9,382
| -3% | -$267K | 0.4% | 86 |
|
|
2014
Q1 | $10.9M | Sell |
358,697
-2,865
| -0.8% | -$85.4K | 0.47% | 74 |
|
|
2013
Q4 | $10.5M | Buy |
361,562
+1,738
| +0.5% | +$50.6K | 0.47% | 70 |
|
|
2013
Q3 | $9.81M | Sell |
359,824
-141
| -0% | -$3.84K | 0.48% | 70 |
|
|
2013
Q2 | $9.57M | Buy |
+359,965
| New | +$9.95M | 0.5% | 63 |
|
Other funds holding PFE
Cullen/Frost Bankers's PFE Position: Q2 2026 in Review
Cullen/Frost Bankers increased its Pfizer (PFE) stake by 3.1% in Q2 2026, buying an estimated $164K and bringing the position to 209,637 shares worth $5.05M. The position accounts for 0.05% of the portfolio, ranked #223.
Cullen/Frost Bankers first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $30.6M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cullen/Frost Bankers held 209,637 shares of Pfizer worth $5.05M as of Q2 2026.
- Cullen/Frost Bankers bought 6,282 Pfizer shares in Q2 2026, an estimated $164K.
- Pfizer made up 0.05% of Cullen/Frost Bankers's portfolio in Q2 2026, its #223 holding.
- Cullen/Frost Bankers first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Cullen/Frost Bankers's Pfizer position peaked at $30.6M in Q4 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.